ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Interest Income
Income earned on cash, deposits, and investments held by the company.
Interest Income history
Currency unavailable · from the income statement
No Interest Income data reported for this period type.
Interest Income vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $12.89M USD | +22.8% | — | 18.0% | |
| LTM Mar 2026 | $10.88M USD | -17.0% | +64.0% | 33.9% | |
| LTM Mar 2026 | $9.27M USD | -47.9% | +57.6% | 20.4% | |
| LTM Mar 2026 | $4.98M USD | +23.6% | — | 123.4% | |
| LTM Mar 2026 | $1.59M USD | -3.2% | — | — | |
| LTM Mar 2026 | $1.04M USD | -74.2% | +32.8% | 1.3% | |
| LTM Mar 2026 | €852.58K EUR | -60.2% | +176.5% | 6.3% | |
| LTM Mar 2026 | $0 USD | — | +148.8% | 0.0% | |
| FY2025 | $0 USD | — | — | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -17.0% | +64.0% | 12.2% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.